Hint mode is switched on Switch off
Cbonds API
Integrate prices, fundamentals and corporate actions into your workflow

Get Global Stock Data via API

  • Prices & history
  • Fundamentals
  • Dividends & corporate actions

Renalytix AI, ordinary share
RENX, GB00BYWL4Y04

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access
Add a stock to WL
Choose all Reset all
Save Close
Renalytix AI, сountry — United Kingdom
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Latest quotes

Try in 7-days Trial access

  • Get full online access to the database
  • Use our powerful bond screener
  • Track bond prices from 400+ sources
  • Smart Portfolio Monitoring
Unlock Data
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Issuer

Profile
Renalytix AI Plc develops artificial intelligence (AI) enabled clinical decision support solutions for kidney disease. It is developing KidneyIntelX, an AI-enabled, clinical-laboratory based solution that supports physician decision making by improving identification, prediction, and risk stratification ...
Renalytix AI Plc develops artificial intelligence (AI) enabled clinical decision support solutions for kidney disease. It is developing KidneyIntelX, an AI-enabled, clinical-laboratory based solution that supports physician decision making by improving identification, prediction, and risk stratification of patients with kidney disease.
Show more Hide
  • Issuer
  • Full borrower / issuer name
    Renalytix AI Plc
  • Industry
    Medical Services

Other stocks and deposit receipts

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    RNLX
  • Placement
    17.07.2020
  • Lock up period
    180
  • Number of papers
    5,485,000
  • Volume of raised funds
    74.05 mln USD
  • Raised funds in USD
    -
  • Placement share
    15.58%
  • Final placement price
    13.5 USD
  • Price change since placement date
    -100%
  • By capitalization
    475.31 mln USD

Indicators

IFRS/US GAAP reports

  • 2024

  • 2023

  • 2022

  • 2021

  • 2019

    • News

    All organization news

    Holders

    Industry Leaders

    Registration is required to get access.